Comments
Loading...

Cronos Group

CRONNASDAQ
Logo brought to you by Benzinga Data
$1.91
-0.01-0.52%
Pre-Market: 5:04 PM EDT
Q4 2024 earnings tomorrow on Thu Feb 27th before the market open
Conference call scheduled tomorrow at 8:30 AM Click to view the webcast

Cronos Group (NASDAQ:CRON) Stock Quotes, Forecast and News Summary

Cronos Group Stock (NASDAQ: CRON) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.40.00 / 1.41M
Day Range- - -
52 Wk Range1.83 - 3.14
Market Cap$730.18M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
40
Short Interest
1.88%
Days to Cover3.2
About
Sector
Healthcare
Industry
N/A
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cann...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRON

FAQ

Q

How do I buy Cronos Group (CRON) stock?

A

You can purchase shares of Cronos Group (NASDAQ:CRON) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cronos Group (CRON) competitors?

A

There are no as such competitors for Cronos Group.

Q

What is the forecast, or price target, for Cronos Group (CRON) stock?

A

Cronos Group has a consensus price target of $3.00.

Q

What is the current price for Cronos Group (CRON)?

A

The stock price for Cronos Group (NASDAQ: CRON) is $1.91 last updated February 24, 2025 at 5:04 PM EST.

Q

Does Cronos Group (CRON) pay a dividend?

A

There are no upcoming dividends for Cronos Group.

Q

When is Cronos Group (NASDAQ:CRON) reporting earnings?

A

Cronos Group’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Q

Is Cronos Group (CRON) going to split?

A

There is no upcoming split for Cronos Group.

Q

What sector and industry does Cronos Group (CRON) operate in?

A

Cronos Group is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.